Skip to main content
. 2019 Jun 20;5(1):e000542. doi: 10.1136/bmjsem-2019-000542

Table 4.

Biochemical markers altered in overtraining syndrome

Altered markers Level of alteration (overt, relative or exacerbated)*
Insulin tolerance test (ITT)
  • Cortisol during hypoglycaemia in response to ITT (μg/dL)

  • Cortisol 30′ after hypoglycaemia in response to ITT (μg/dL)

  • Cortisol increase during ITT (μg/dL)

Relative
  • ACTH 30′ after hypoglycaemia in response to ITT (pg/mL)

  • ACTH change during ITT (pg/mL)

Overt
  • Growth hormone (GH) during hypoglycaemia in response to ITT (μg/L)

  • GH 30′ after hypoglycaemia in response to ITT (μg/L)

Relative
  • Prolactin during hypoglycaemia in response to ITT (ng/mL)

  • Prolactin 30′ after hypoglycaemia in response to ITT (ng/mL)

  • Change in prolactin during ITT (ng/mL)

Relative
Basal hormones
 Basal GH (μg/L) Relative
 Basal prolactin (μg/mL) Relative
 Oestradiol (pg/mL) Overt
 Total testosterone (ng/dL) Relative
 Testosterone-to-oestradiol ratio Overt
Other hormones
 Total catecholamines (μg/12 hours) Exacerbated
 Nocturnal urinary norepinephrine (μg/12 hours) Overt
 30′ after awakening salivary cortisol (ng/dL) Relative
Immunological and muscular markers
 Creatine kinase (U/L) Exacerbated
 Lactate (nmol/L) Relative
 Lymphocytes (/mm3) Relative
 Neutrophils (/mm3) Relative
 Platelet to lymphocyte ratio Relative

Relative: Unaltered when compared with general population, but altered when compared with healthy athletes.

Exacerbated: Changes normally observed in healthy athletes that are exacerbated in the presence of overtraining syndrome.

*Overt: Markedly and exclusively altered in overtraining syndrome, when compared with both the healthy athletes and the healthy non-physically active subjects.

ACTH, adrenocorticotropic hormone.